In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene-Reference-Cited by-同舟云学术

In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene

Published:2009-06-08 Issue: Volume: Page:
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Larochelle Andre,Choi Uimook,Shou Yan,Naumann Nora,Loktionova Natalia A.,Clevenger Joshua R.,Krouse Allen,Metzger Mark,Donahue Robert E.,Kang Elizabeth,Stewart Clinton,Persons Derek,Malech Harry L.,Dunbar Cynthia E.,Sorrentino Brian P.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference63 articles.

1. Genotoxicity of Retroviral Integration In Hematopoietic Cells

2. Development of gene therapy for blood disorders

3. Hematopoietic stem cell gene therapy: dead or alive?

4. Stem cell gene transfer—efficacy and safety in large animal studies

5. Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5/35++ vectors;Molecular Therapy - Methods & Clinical Development;2022-03

2. Mesenchymal stem cells as carrier of the therapeutic agent in the gene therapy of blood disorders;Journal of Cellular Physiology;2019-11-06

3. In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia;Journal of Clinical Investigation;2018-12-18

4. Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies;Molecular Therapy - Methods & Clinical Development;2018-06

5. A Combined In Vivo HSC Transduction/Selection Approach Results in Efficient and Stable Gene Expression in Peripheral Blood Cells in Mice;Molecular Therapy - Methods & Clinical Development;2018-03